SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022416
Filing Date
2020-05-07
Accepted
2020-05-07 09:01:28
Documents
71
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q grts-10q_20200331.htm 10-Q 2277387
2 EX-10.1 grts-ex101_143.htm EX-10.1 105459
3 EX-31.1 grts-ex311_11.htm EX-31.1 20210
4 EX-31.2 grts-ex312_8.htm EX-31.2 20222
5 EX-32.1 grts-ex321_9.htm EX-32.1 13316
  Complete submission text file 0001564590-20-022416.txt   8164179

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT grts-20200331.xml EX-101.INS 1871536
7 XBRL TAXONOMY EXTENSION SCHEMA grts-20200331.xsd EX-101.SCH 58372
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grts-20200331_cal.xml EX-101.CAL 52245
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grts-20200331_def.xml EX-101.DEF 135099
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20200331_lab.xml EX-101.LAB 411326
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20200331_pre.xml EX-101.PRE 311567
Mailing Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608 (510) 871-6100
Gritstone Oncology, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38663 | Film No.: 20854799
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences